Introducing Professor Matthew Ringel
We are excited to announce that Professor Matthew Ringel has been appointed as the new Editor-in-Chief of Endocrine-Related Cancer. He is the Ralph W. Kurtz Professor of Medicine at The Ohio State University, USA. He will officially take over leadership of the journal from Professor Charis Eng on 1st January 2021.
Professor Ringel’s research focuses on basic and translational thyroid cancer, including cell signalling, genetics and cancer metastasis. He hopes to build on the journal’s strong position in the community by strengthening links with the journal’s associated societies, and by using the journal as a vehicle to support the career development of early-career researchers.
To find out more about Professor Ringel’s plans for the journal, and what he does for fun, watch this short video interview.
To offer more of an insight into the research interests of Professor Ringel, see below for a selection of the articles recently published by his group in Endocrine-Related Cancer.
MAPK- and AKT-activated thyroid cancers are sensitive to group I PAK inhibition
Christina M Knippler et al.
Sdhd ablation promotes thyroid tumorigenesis by inducing a stem-like phenotype
Amruta Ashtekar et al.
Thyroid nodules and cancer management guidelines: comparisons and controversies
Fadi Nabhan and Matthew Ringel